An Explorative Review on Advanced Approaches to Overcome Bacterial Resistance by Curbing Bacterial Biofilm Formation

References

• Lood R, Frick IM. Protein-Based Strategies to Identify and Isolate Bacterial Virulence Factors. In: Bacterial Pathogenesis. Springer; 2017:3–15.
   Google Scholar
• Bassegoda A, Ivanova K, Ramon E, Tzanov T. Strategies to prevent the occurrence of resistance against antibiotics by using advanced materials. Appl Microbiol Biotechnol. 2018;102(5):2075–2089.
   PubMed Web of Science ®Google Scholar
• Diard M, Hardt WD. Evolution of bacterial virulence. FEMS Microbiol Rev. 2017;41(5):679–697.
   PubMed Web of Science ®Google Scholar
• Sharma D, Misba L, Khan AU. Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob Resist Infect Control. 2019;8(1):1–10.
   PubMedGoogle Scholar
• Banerjee D, Shivapriya PM, Gautam PK, Misra K, Sahoo AK, Samanta SK. A review on basic biology of bacterial biofilm infections and their treatments by nanotechnology-based approaches. Proce National Acad Sci India Section B. 2019;90(2):243–259.
   Google Scholar
• Nordenfelt P, Collin M. Bacterial Pathogenesis: Methods and Protocols. Springer; 2017.
   Google Scholar
• Limoli DH, Jones CJ, Wozniak DJ. Bacterial extracellular polysaccharides in biofilm formation and function. Microbiol Spectr. 2015;3(3):29.
   Google Scholar
• Hengge R. Targeting bacterial biofilms by the green tea polyphenol EGCG. Molecules. 2019;24(13):2403.
   PubMed Web of Science ®Google Scholar
• Karygianni L, Ren Z, Koo H, Thurnheer T. Biofilm Matrixome: extracellular components in structured microbial communities. Trends Microbiol. 2020;28(8):668–681.
   PubMed Web of Science ®Google Scholar
• Solano C, Echeverz M, Lasa I. Biofilm dispersion and quorum sensing. Curr Opin Microbiol. 2014;18:96–104. doi:
   PubMed Web of Science ®Google Scholar
• Sahu PK, Iyer PS, Barage SH, Sonawane KD, Chopade BA. Characterization of the algC Gene Expression Pattern in the Multidrug Resistant Acinetobacter baumannii AIIMS 7 and Correlation with Biofilm Development on Abiotic Surface. Sci World J. 2014;2014:1–14.
   Google Scholar
• Beloin C, McDougald D. Speciality Grand Challenge for “Biofilms.”. Front Cell Infect Microbiol. 2021;11:99.
   Web of Science ®Google Scholar
• Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. The biology and future prospects of antivirulence therapies. Nat Rev Microbiol. 2008;6(1):17–27.
   PubMed Web of Science ®Google Scholar
• Heras B, Scanlon MJ, Martin JL. Targeting virulence not viability in the search for future antibacterials. Br J Clin Pharmacol. 2015;79(2):208–215.
   PubMed Web of Science ®Google Scholar
• Uruén C, Chopo-Escuin G, Tommassen J, Mainar-Jaime RC, Arenas J. Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance. Antibiotics. 2021;10(1):3.
   Google Scholar
• O’Toole G, Kaplan HB, Kolter R. Biofilm Formation as Microbial Development. Annu Rev Microbiol. 2000;54(1):49–79.
   PubMed Web of Science ®Google Scholar
• Lin YK, Yang SC, Hsu CY, Sung JT, Fang JY. The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin. Molecules. 2021;26:21.
   Web of Science ®Google Scholar
• Singh A, Amod A, Pandey P, et al. Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies. Biomed Mater. 2022;17(2):022003.
   Google Scholar
• Silva NBS, Marques LA, Röder DDB. Diagnosis of biofilm infections: current methods used, challenges and perspectives for the future. J Appl Microbiol. 2021;131(5):2148–2160.
   PubMed Web of Science ®Google Scholar
• Blair JMA, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJV. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42–51.
   PubMed Web of Science ®Google Scholar
• Ghai I, Ghai S. Understanding antibiotic resistance via outer membrane permeability. Infect Drug Resist. 2018;11:523–530.
   PubMed Web of Science ®Google Scholar
• Tang SS, Apisarnthanarak A, Hsu LY. Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria. Adv Drug Deliv Rev. 2014;78:3–13.
   PubMed Web of Science ®Google Scholar
• Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, Handelsman J. Call of the wild: antibiotic resistance genes in natural environments. Nat Rev Microbiol. 2010;8(4):251–259.
   PubMed Web of Science ®Google Scholar
• Munita JM, Arias CA. Mechanisms of Antibiotic Resistance. Microbiol Spectr. 2016;23(5):464–472.
   Google Scholar
• Varela MF, Stephen J, Lekshmi M, et al. Bacterial resistance to antimicrobial agents. Antibiotics. 2021;10(5):593.
   Google Scholar
• Ronin D, Boyer J, Alban N, Natoli RM, Johnson A, Kjellerup BV. Current and novel diagnostics for orthopedic implant biofilm infections: a review. APMIS. 2022;130(2):59–81.
   PubMed Web of Science ®Google Scholar
• Wannigama DL, Hurst C, Pearson L, et al. Simple fluorometric-based assay of antibiotic effectiveness for Acinetobacter baumannii biofilms. Sci Rep. 2019;9(1):1–14.
   PubMedGoogle Scholar
• Wannigama DL, Hurst C, Hongsing P, et al. A rapid and simple method for routine determination of antibiotic sensitivity to biofilm populations of Pseudomonas aeruginosa. Ann Clin Microbiol Antimicrob. 2020;19(1):1–8.
   PubMed Web of Science ®Google Scholar
• Sedarat Z, Taylor-Robinson AW. Biofilm formation by pathogenic bacteria: applying a staphylococcus aureus model to appraise potential targets for therapeutic intervention. Pathogens. 2022;11:4.
   Web of Science ®Google Scholar
• Gedefie A, Demsis W, Ashagrie M, et al. Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: a review. Infect Drug Resist. 2021;14:3711–3719.
   PubMed Web of Science ®Google Scholar
• Goldman L. Pseudomonas and Related Gram-Negative Bacillary Infections. In: Falagas ME, Rafailidis PI, editors. Goldman-Cecil Medicine. 26th ed. Elsevier, Inc; 2020:1931–1936.
   Google Scholar
• Moradali MF, Ghods S, Rehm BHA. Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence. Front Cell Infect Microbiol. 2017;7:39.
   PubMed Web of Science ®Google Scholar
• Hu Y, Liu C, Wang Q, et al. Emergence and expansion of a carbapenem-resistant pseudomonas aeruginosa clone are associated with plasmid-borne bla kpc-2 and virulence-related genes. mSystems. 2021;6(3):e00154–21.
   PubMed Web of Science ®Google Scholar
• Laverty G, Gorman SP, Gilmore BF. Biomolecular mechanisms of Pseudomonas aeruginosa and Escherichia coli biofilm formation. Pathogens. 2014;3(3):596–632.
   PubMedGoogle Scholar
• Thöming JG, Tomasch J, Preusse M, et al. Parallel evolutionary paths to produce more than one Pseudomonas aeruginosa biofilm phenotype. Npj Biofilms and Microbiomes. 2020;6(1):1–13.
   PubMed Web of Science ®Google Scholar
• Huszczynski SM, Lam JS, Khursigara CM. The role of Pseudomonas aeruginosa lipopolysaccharide in bacterial pathogenesis and physiology. Pathogens. 2020;9:1.
   Web of Science ®Google Scholar
• Wang S, Xiang D, Tian F, Ni M. Lipopolysaccharide from biofilm-forming Pseudomonas aeruginosa PAO1 induces macrophage hyperinflammatory responses. J Med Microbiol. 2021;70:4.
   Web of Science ®Google Scholar
• Ciofu O, Tolker-Nielsen T. Tolerance and resistance of pseudomonas aeruginosa biofilms to antimicrobial agents-how P. aeruginosa Can escape antibiotics. Front Microbiol. 2019;10:913.
   PubMed Web of Science ®Google Scholar
• Liang Z, Rybtke M, Kragh KN, et al. Transcription of the Alginate Operon in Pseudomonas aeruginosa Is Regulated by c-di-GMP. Microbiol Spectr. 2022;10(4):e00675–22.
   PubMed Web of Science ®Google Scholar
• Skariyachan S, Sridhar VS, Packirisamy S, Kumargowda ST, Challapilli SB. Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal. Folia Microbiol (Praha). 2018;63(4):413–432.
   PubMed Web of Science ®Google Scholar
• Yan S, Wu G. Can biofilm be reversed through quorum sensing in pseudomonas aeruginosa? Front Microbiol. 2019;10:1582.
   PubMedGoogle Scholar
• Muhammad MH, Idris AL, Fan X, et al. Beyond risk: bacterial biofilms and their regulating approaches. Front Microbiol. 2020;11:928.
   PubMed Web of Science ®Google Scholar
• Abdelraheem WM, Abdelkader AE, Mohamed ES, Mohammed MS. Detection of biofilm formation and assessment of biofilm genes expression in different Pseudomonas aeruginosa clinical isolates. Meta Gene. 2020;23:100646.
   Web of Science ®Google Scholar
• Azam MW, Khan AU. Updates on the pathogenicity status of Pseudomonas aeruginosa. Drug Discov Today. 2019;24(1):350–359.
   PubMed Web of Science ®Google Scholar
• O’Loughlin CT, Miller LC, Siryaporn A, Drescher K, Semmelhack MF, Bassler BL. A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation. Proc Natl Acad Sci U S A. 2013;110(44):17981–17986.
   PubMed Web of Science ®Google Scholar
• Thi MTT, Wibowo D, Rehm BHA. Pseudomonas aeruginosa Biofilms. Int J Mol Sci. 2020;21(22):1–25.
   Web of Science ®Google Scholar
• Chadha J, Harjai K, Chhibber S. Revisiting the virulence hallmarks of Pseudomonas aeruginosa: a chronicle through the perspective of quorum sensing. Environ Microbiol. 2022;24(6):2630–2656.
   PubMed Web of Science ®Google Scholar
• Pye CC, Yu AA, Weese JS. Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro. Vet Dermatol. 2013;24(4):446–e99.
   PubMed Web of Science ®Google Scholar
• Miryala SK, Anbarasu A, Ramaiah S. Systems biology studies in Pseudomonas aeruginosa PA01 to understand their role in biofilm formation and multidrug efflux pumps. Microb Pathog. 2019;136:103668.
   PubMed Web of Science ®Google Scholar
• Milivojevic D, Šumonja N, Medić S, et al. Biofilm-forming ability and infection potential of Pseudomonas aeruginosa strains isolated from animals and humans. Pathog Dis. 2018;76:4.
   Web of Science ®Google Scholar
• Orsi GB, Scorzolini L, Franchi C, Mondillo V, Rosa G, Venditti M. Hospital-acquired infection surveillance in a neurosurgical intensive care unit. J Hosp Infect. 2006;64(1):23–29.
   PubMed Web of Science ®Google Scholar
• Azzopardi EA, Azzopardi E, Camilleri L, et al. Gram Negative Wound Infection in Hospitalised Adult Burn Patients-Systematic Review and Metanalysis-. McDowell A. PLoS One. 2014;9(4):e95042.
   PubMed Web of Science ®Google Scholar
• Watkins K, Unnikrishnan M. New strategies and targets for antibacterial discovery. In: Drug Discovery Targeting Drug-Resistant Bacteria. Elsevier; 2020:249–272.
   Google Scholar
• Rezzoagli C, Archetti M, Mignot I, Baumgartner M, Kümmerli R. Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa. PLoS Biol. 2020;18(8):e3000805.
   PubMed Web of Science ®Google Scholar
• Morris FC, Dexter C, Kostoulias X, Uddin MI, Peleg AY. The mechanisms of disease caused by Acinetobacter baumannii. Front Microbiol. 2019;10:1601.
   PubMed Web of Science ®Google Scholar
• Geisinger E, Isberg RR. Interplay between antibiotic resistance and virulence during disease promoted by multidrug-resistant bacteria. J Infect Dis. 2017;215(suppl_1):S9–S17.
   PubMedGoogle Scholar
• Galac MR, Snesrud E, Lebreton F, et al. A diverse panel of clinical Acinetobacter baumannii for research and development. Antimicrob Agents Chemother. 2020;64(10):e00840–20.
   PubMed Web of Science ®Google Scholar
• Salmani A, Shakerimoghaddam A, Pirouzi A, Delkhosh Y, Eshraghi M. Correlation between biofilm formation and antibiotic susceptibility pattern in Acinetobacter baumannii MDR isolates retrieved from burn patients. Gene Rep. 2020;21:100816.
   Web of Science ®Google Scholar
• Lee CR, Lee JH, Park M, et al. Biology of Acinetobacter baumannii: pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front Cell Infect Microbiol. 2017;7:55.
   PubMed Web of Science ®Google Scholar
• Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges. Clin Microbiol Rev. 2017;30(1):409–447.
   PubMed Web of Science ®Google Scholar
• Choi CH, Lee EY, Lee YC, et al. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol. 2005;7(8):1127–1138.
   PubMed Web of Science ®Google Scholar
• Kim SW, Choi CH, Moon DC, et al. Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. FEMS Microbiol Lett. 2009;301(2):224–231.
   PubMed Web of Science ®Google Scholar
• Lee JS, Choi CH, Kim JW, Lee JC. Acinetobacter baumannii outer membrane protein a induces dendritic cell death through mitochondrial targeting. J Microbiol. 2010;48(3):387–392.
   PubMed Web of Science ®Google Scholar
• Fernández-Cuenca F, Smani Y, Gómez-Sánchez MC, et al. Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like. Int J Antimicrob Agents. 2011;38(6):548–549.
   PubMed Web of Science ®Google Scholar
• Smani Y, McConnell MJ, Pachón J. Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells. PLoS One. 2012;7(4):e33073.
   PubMed Web of Science ®Google Scholar
• Rumbo C, Tomás M, Moreira EF, et al. The Acinetobacter baumannii Omp33-36 porin is a virulence factor that induces apoptosis and modulates autophagy in human cells. Infect Immun. 2014;82(11):4666–4680.
   PubMed Web of Science ®Google Scholar
• Wang N, Ozer EA, Mandel MJ, Hauser AR. Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung. mBio. 2014;5(3):1163–1177.
   PubMed Web of Science ®Google Scholar
• Huang W, Yao Y, Wang S, et al. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii. Sci Rep. 2016;6(1):1–12.
   PubMedGoogle Scholar
• Smani Y, Dominguez-Herrera J, Pachon J. Association of the Outer Membrane Protein Omp33 With Fitness and Virulence of Acinetobacter baumannii. J Infect Dis. 2013;208(10):1561–1570.
   PubMed Web of Science ®Google Scholar
• Schweppe DK, Harding C, Chavez JD, et al. Host-Microbe Protein Interactions during Bacterial Infection. Chem Biol. 2015;22(11):1521–1530.
   PubMedGoogle Scholar
• Gaddy JA, Tomaras AP, Actis LA. The Acinetobacter baumannii 19606 OmpA Protein Plays a Role in Biofilm Formation on Abiotic Surfaces and in the Interaction of This Pathogen with Eukaryotic Cells. Infect Immun. 2009;77(8):3150–3160.
   PubMed Web of Science ®Google Scholar
• Lees-Miller RG, Iwashkiw JA, Scott NE, et al. A common pathway for O -linked protein-glycosylation and synthesis of capsule in Acinetobacter baumannii. Mol Microbiol. 2013;89(5):816–830.
   PubMed Web of Science ®Google Scholar
• Russo TA, Luke NR, Beanan JM, et al. The K1 Capsular Polysaccharide of Acinetobacter baumannii Strain 307-0294 Is a Major Virulence Factor. Infect Immun. 2010;78(9):3993–4000.
   PubMed Web of Science ®Google Scholar
• Iwashkiw JA, Seper A, Weber BS, et al. Identification of a General O-linked Protein Glycosylation System in Acinetobacter baumannii and Its Role in Virulence and Biofilm Formation. PLoS Pathog. 2012;8(6):e1002758.
   PubMed Web of Science ®Google Scholar
• Geisinger E, Isberg RR. Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii. PLoS Pathog. 2015;11(2):e1004691.
   PubMed Web of Science ®Google Scholar
• Luke NR, Sauberan SL, Russo TA, et al. Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis. Infect Immun. 2010;78(5):2017–2023.
   PubMed Web of Science ®Google Scholar
• Lin L, Tan B, Pantapalangkoor P, et al. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis. Pirofski L anne, ed. mBio. 2012;3:5.
   Web of Science ®Google Scholar
• McQueary CN, Kirkup BC, Si Y, et al. Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility. J Microbiol. 2012;50(3):434–443.
   PubMed Web of Science ®Google Scholar
• McConnell MJ, Actis L, Pachón J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev. 2013;37(2):130–155.
   PubMed Web of Science ®Google Scholar
• Beceiro A, Moreno A, Fernández N, et al. Biological Cost of Different Mechanisms of Colistin Resistance and Their Impact on Virulence in Acinetobacter baumannii. Antimicrob Agents Chemother. 2014;58(1):518–526.
   PubMed Web of Science ®Google Scholar
• Erridge C, Moncayo-Nieto OL, Morgan R, Young M, Poxton IR. Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling. J Med Microbiol. 2007;56(2):165–171.
   PubMed Web of Science ®Google Scholar
• Camarena L, Bruno V, Euskirchen G, Poggio S, Snyder M. Molecular Mechanisms of Ethanol-Induced Pathogenesis Revealed by RNA-Sequencing. Roy CR. PLoS Pathog. 2010;6(4):e1000834.
   PubMed Web of Science ®Google Scholar
• Jacobs AC, Hood I, Boyd KL, et al. Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect Immun. 2010;78(5):1952–1962.
   PubMed Web of Science ®Google Scholar
• Stahl J, Bergmann H, Göttig S, Ebersberger I, Averhoff B. Acinetobacter baumannii virulence is mediated by the concerted action of three phospholipases D. PLoS One. 2015;10(9):e0138360.
   PubMed Web of Science ®Google Scholar
• Fiester SE, Arivett BA, Schmidt RE, et al. Iron-Regulated phospholipase C Activity contributes to the cytolytic activity and virulence of Acinetobacter baumannii. PLoS One. 2016;11(11):e0167068.
   PubMed Web of Science ®Google Scholar
• Johnson TL, Waack U, Smith S, Mobley H, Sandkvist M. Acinetobacter baumannii is dependent on the type II secretion system and its substrate LipA for lipid utilization and in vivo fitness. J Bacteriol. 2016;198(4):711–719.
   Web of Science ®Google Scholar
• Kwon SO, Gho YS, Lee JC, Kim S. Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. FEMS Microbiol Lett. 2009;297(2):150–156.
   PubMed Web of Science ®Google Scholar
• Jin JS, Kwon SO, Moon DC, et al. Acinetobacter baumannii secretes cytotoxic outer membrane protein a via outer membrane vesicles. PLoS One. 2011;6(2):e17027.
   PubMed Web of Science ®Google Scholar
• Rumbo C, Fernández-Moreira E, Merino M, et al. Horizontal Transfer of the OXA-24 Carbapenemase Gene via Outer Membrane Vesicles: a New Mechanism of Dissemination of Carbapenem Resistance Genes in Acinetobacter baumannii. Antimicrob Agents Chemother. 2011;55(7):3084–3090.
   PubMed Web of Science ®Google Scholar
• Moon DC, Choi CH, Lee JH, et al. Acinetobacter baumannii outer membrane protein a modulates the biogenesis of outer membrane vesicles. J Microbiol. 2012;50(1):155–160.
   PubMed Web of Science ®Google Scholar
• Jun SH, Lee JH, Kim BR, et al. Acinetobacter baumannii Outer Membrane Vesicles Elicit a Potent Innate Immune Response via Membrane Proteins. PLoS One. 2013;8(8):e71751.
   PubMed Web of Science ®Google Scholar
• Li ZT, Zhang RL, Bi XG, et al. Outer membrane vesicles isolated from two clinical Acinetobacter baumannii strains exhibit different toxicity and proteome characteristics. Microb Pathog. 2015;81:46–52.
   PubMed Web of Science ®Google Scholar
• Nho JS, Jun SH, Oh MH, et al. Acinetobacter nosocomialis secretes outer membrane vesicles that induce epithelial cell death and host inflammatory responses. Microb Pathog. 2015;81:39–45.
   PubMed Web of Science ®Google Scholar
• Nairn BL, Lonergan ZR, Wang J, et al. The Response of Acinetobacter baumannii to Zinc Starvation. Cell Host Microbe. 2016;19(6):826–836.
   PubMed Web of Science ®Google Scholar
• Hood MI, Mortensen BL, Moore JL, et al. Identification of an Acinetobacter baumannii Zinc Acquisition System that Facilitates Resistance to Calprotectin-mediated Zinc Sequestration. PLoS Pathog. 2012;8(12):e1003068.
   PubMed Web of Science ®Google Scholar
• Ali HM, Salem MZM, El-Shikh MS, Megeed AA, Alogaibi YA, Talea IA. Investigation of the Virulence Factors and Molecular Characterization of the Clonal Relations of Multidrug-Resistant Acinetobacter baumannii Isolates. J AOAC Int. 2017;100(1):152–158.
   PubMed Web of Science ®Google Scholar
• Zimbler DL, Park TM, Arivett BA, et al. Stress response and virulence functions of the Acinetobacter baumannii NfuA Fe-S scaffold protein. J Bacteriol. 2012;194(11):2884–2893.
   PubMed Web of Science ®Google Scholar
• Penwell WF, Arivett BA, Actis LA. The Acinetobacter baumannii entA Gene Located Outside the Acinetobactin Cluster Is Critical for Siderophore Production, Iron Acquisition and Virulence. PLoS One. 2012;7(5):e36493.
   PubMed Web of Science ®Google Scholar
• Gaddy JA, Actis LA, Arivett BA, Mcconnell MJ, Rafael LR, Pachón J. Role of Acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect Immun. 2012;80(3):1015–1024.
   PubMed Web of Science ®Google Scholar
• Juttukonda LJ, Chazin WJ, Skaar EP, Sperandio V. Acinetobacter baumannii coordinates urea metabolism with metal import to resist host-mediated metal limitation. mBio. 2016;7(5):5. doi:
   Web of Science ®Google Scholar
• Elhosseiny NM, El-Tayeb OM, Yassin AS, Lory S, Attia AS. The secretome of Acinetobacter baumannii ATCC 17978 type II secretion system reveals a novel plasmid encoded phospholipase that could be implicated in lung colonization. Int J Med Microbiol. 2016;306(8):633–641.
   PubMed Web of Science ®Google Scholar
• Harding CM, Kinsella RL, Palmer LD, Skaar EP, Feldman MF. Medically Relevant Acinetobacter Species Require a Type II Secretion System and Specific Membrane-Associated Chaperones for the Export of Multiple Substrates and Full Virulence. PLoS Pathog. 2016;12:1.
   Web of Science ®Google Scholar
• Carruthers MD, Nicholson PA, Tracy EN, Munson RS. Acinetobacter baumannii Utilizes a Type VI Secretion System for Bacterial Competition. PLoS One. 2013;8(3):e59388.
   PubMed Web of Science ®Google Scholar
• Jones CL, Clancy M, Honnold C, et al. Fatal Outbreak of an Emerging Clone of Extensively Drug-Resistant Acinetobacter baumannii with Enhanced Virulence. Clin Infect Dis. 2015;61(2):145–154.
   PubMed Web of Science ®Google Scholar
• Repizo GD, Gagné S, Foucault-Grunenwald ML, et al. Differential Role of the T6SS in Acinetobacter baumannii Virulence. PLoS One. 2015;10(9):e0138265.
   PubMed Web of Science ®Google Scholar
• Ruiz FM, Santillana E, Spínola-Amilibia M, Torreira E, Culebras E, Romero A. Crystal Structure of Hcp from Acinetobacter baumannii: a Component of the Type VI Secretion System. PLoS One. 2015;10(6):e0129691.
   PubMed Web of Science ®Google Scholar
• Bentancor L, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litrán T. Evaluation of the Trimeric Autotransporter Ata as a Vaccine Candidate against Acinetobacter baumannii Infections. Infect Immun. 2012;80(10):3381–3388.
   PubMed Web of Science ®Google Scholar
• Russo TA, MacDonald U, Beanan JM, et al. Penicillin‐Binding Protein 7/8 Contributes to the Survival of Acinetobacter baumannii In Vitro and In Vivo. J Infect Dis. 2009;199(4):513–521.
   PubMed Web of Science ®Google Scholar
• Sechi LA, Karadenizli A, Deriu A, et al. PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. Medical Science Monitor. 2004;10(6):180–184.
   Web of Science ®Google Scholar
• Koenigs A, Stahl J, Averhoff B, et al. CipA of Acinetobacter baumannii Is a Novel Plasminogen Binding and Complement Inhibitory Protein. J Infect Dis. 2016;213(9):1388–1399.
   PubMed Web of Science ®Google Scholar
• Koenigs A, Zipfel PF, Kraiczy P. Translation elongation factor Tuf of Acinetobacter baumannii is a plasminogen-binding protein. PLoS One. 2015;10(7):e0134418.
   PubMed Web of Science ®Google Scholar
• Aranda J, Bardina C, Beceiro A, et al. Acinetobacter baumannii RecA protein in repair of DNA damage, antimicrobial resistance, general stress response, and virulence. J Bacteriol. 2011;193(15):3740–3747.
   PubMed Web of Science ®Google Scholar
• Gebhardt MJ, Gallagher LA, Jacobson RK, et al. Joint Transcriptional Control of Virulence and Resistance to Antibiotic and Environmental Stress in Acinetobacter baumannii. mBio. 2015;6:6.
   Web of Science ®Google Scholar
• Liu D, Liu ZS, Hu P, et al. Characterization of surface antigen protein 1 (SurA1) from Acinetobacter baumannii and its role in virulence and fitness. Vet Microbiol. 2016;186:126–138.
   PubMed Web of Science ®Google Scholar
• Elhosseiny NM, Amin MA, Yassin AS, Attia AS. Acinetobacter baumannii universal stress protein A plays a pivotal role in stress response and is essential for pneumonia and sepsis pathogenesis. Int J Med Microbiol. 2015;305(1):114–123.
   PubMed Web of Science ®Google Scholar
• Cerqueira GM, Kostoulias X, Khoo C, et al. A Global Virulence Regulator in Acinetobacter baumannii and Its Control of the Phenylacetic Acid Catabolic Pathway. J Infect Dis. 2014;210(1):46–55.
   PubMed Web of Science ®Google Scholar
• Bhuiyan MS, Ellett F, Murray GL, et al. Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis. Proc Natl Acad Sci U S A. 2016;113(34):9599–9604.
   PubMed Web of Science ®Google Scholar
• Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology. 2003;149(12):3473–3484.
   PubMedGoogle Scholar
• Tomaras AP, Flagler MJ, Dorsey CW, Gaddy JA, Actis LA. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology. 2008;154(11):3398–3409.
   PubMedGoogle Scholar
• Tipton KA, Rather PN. An ompR-envZ Two-Component System Ortholog Regulates Phase Variation, Osmotic Tolerance, Motility, and Virulence in Acinetobacter baumannii Strain AB5075. J Bacteriol. 2017;199:3.
   Web of Science ®Google Scholar
• Subashchandrabose S, Smith S, DeOrnellas V, et al. Acinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection. mSphere. 2016;1:1.
   Web of Science ®Google Scholar
• Srinivasan VB, Venkataramaiah M, Mondal A, Rajamohan G. Functional Characterization of AbeD, an RND-Type Membrane Transporter in Antimicrobial Resistance in Acinetobacter baumannii. PLoS One. 2015;10(10):e0141314.
   PubMed Web of Science ®Google Scholar
• Álvarez-fraga L, Pérez A, Rumbo-Feal S, et al. Analysis of the role of the LH92_11085 gene of a biofilm hyper-producing Acinetobacter baumannii strain on biofilm formation and attachment to eukaryotic cells. Virulence. 2016;7(4):443–455.
   PubMed Web of Science ®Google Scholar
• Altınok Ö, Boral B, Ergin A, Eser ÖK. Existence of Biofilm and Biofilm-Associated Virulence Genes in Multi-Drug Resistant Invasive Acinetobacter baumannii Isolates. Mikrobiyol Bul. 2020;54(1):40–49.
   PubMed Web of Science ®Google Scholar
• Colquhoun JM, Rather PN. Insights Into Mechanisms of Biofilm Formation in Acinetobacter baumannii and Implications for Uropathogenesis. Front Cell Infect Microbiol. 2020;10:253.
   PubMed Web of Science ®Google Scholar
• Srisakul S, Wannigama DL, Higgins PG, et al. Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin-sulbactam combination therapy. Sci Rep. 2022;12:1.
   PubMed Web of Science ®Google Scholar
• Toltzis P. Staphylococcus epidermidis and Other Coagulase-Negative Staphylococci. In: Principles and Practice of Pediatric Infectious Diseases. Elsevier; 2018:706–712.e4.
   Google Scholar
• Taylor TA, Unakal CG. Staphylococcus Aureus. StatPearls Publishing; 2020.
   Google Scholar
• Silva V, Capelo JL, Igrejas G, Poeta P. Molecular Epidemiology of Staphylococcus aureus Lineages in Wild Animals in Europe: a Review. Antibiotics. 2020;9:3.
   Google Scholar
• Oliveira D, Borges A, Simões M. Staphylococcus aureus toxins and their molecular activity in infectious diseases. Toxins. 2018;10:6.
   Web of Science ®Google Scholar
• Quave CL, Horswill AR. Flipping the switch: tools for detecting small molecule inhibitors of staphylococcal virulence. Front Microbiol. 2014;5:706.
   PubMed Web of Science ®Google Scholar
• Craft KM, Nguyen JM, Berg LJ, Townsend SD. Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype. Medchemcomm. 2019;10(8):1231–1241.
   PubMed Web of Science ®Google Scholar
• Luther MK, Parente DM, Caffrey AR, et al. Clinical and Genetic Risk Factors for Biofilm-Forming Staphylococcus aureus. Antimicrob Agents Chemother. 2018;62:5.
   Web of Science ®Google Scholar
• Zapotoczna M, O’Neill E, O’Gara JP. Untangling the diverse and redundant mechanisms of Staphylococcus aureus biofilm formation. PLoS Pathog. 2016;12(7):e1005671.
   PubMed Web of Science ®Google Scholar
• Nguyen HTT, Nguyen TH, Otto M. The staphylococcal exopolysaccharide PIA – biosynthesis and role in biofilm formation, colonization, and infection. Comput Struct Biotechnol J. 2020;18:3324–3334.
   PubMed Web of Science ®Google Scholar
• Foster TJ, Geoghegan JA, Ganesh VK, Höök M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol. 2014;12(1):49–62.
   PubMed Web of Science ®Google Scholar
• Foster TJ. Surface Proteins of Staphylococcus aureus. Microbiol Spectr. 2019;7:4.
   Web of Science ®Google Scholar
• Otto M. Staphylococcal Biofilms. Microbiol Spectr. 2018;6(4):658.
   Google Scholar
• Enany S, Alexander LC. The Rise of Virulence and Antibiotic Resistance in Staphylococcus Aureus. InTech; 2017.
   Google Scholar
• Reffuveille F, Josse J, Vallé Q, Mongaret C, Gangloff SC. Staphylococcus aureus Biofilms and their Impact on the Medical Field. In: The Rise of Virulence and Antibiotic Resistance in Staphylococcus Aureus. InTech; 2017:187–214.
   Google Scholar
• Ruhal R, Kataria R. Biofilm patterns in gram-positive and gram-negative bacteria. Microbiol Res. 2021;251:126829.
   PubMedGoogle Scholar
• Jamal M, Ahmad W, Andleeb S, et al. Bacterial biofilm and associated infections. J Chin Med Assoc. 2018;81(1):7–11.
   PubMed Web of Science ®Google Scholar
• Krzyściak P, Chmielarczyk A, Pobiega M, Romaniszyn D, Wójkowska‐Mach J. Acinetobacter baumannii isolated from hospital‐acquired infection: biofilm production and drug susceptibility. APMIS. 2017;125(11):1017–1026.
   PubMed Web of Science ®Google Scholar
• Olsen I. Biofilm-specific antibiotic tolerance and resistance. Eur J Clin Microbiol Infect Dis. 2015;34(5):877–886.
   PubMed Web of Science ®Google Scholar
• Sharma G, Sharma S, Sharma P, et al. Escherichia coli biofilm: development and therapeutic strategies. J Appl Microbiol. 2016;121(2):309–319.
   PubMed Web of Science ®Google Scholar
• Gupta S, Kumar P, Rathi B, et al. Targeting of Uropathogenic Escherichia coli papG gene using CRISPR-dot nanocomplex reduced virulence of UPEC. Sci Rep. 2021;11:1.
   PubMed Web of Science ®Google Scholar
• Law SKK, Tan HS. The role of quorum sensing, biofilm formation, and iron acquisition as key virulence mechanisms in Acinetobacter baumannii and the corresponding anti-virulence strategies. Microbiol Res. 2022;260:127032.
   PubMedGoogle Scholar
• Kaushik V, Tiwari M, Joshi R, Tiwari V. Therapeutic strategies against potential antibiofilm targets of multidrug‐resistant Acinetobacter baumannii. J Cell Physiol. 2022;237(4):2045–2063.
   PubMed Web of Science ®Google Scholar
• Trifan A, Luca SV, Greige-Gerges H, Miron A, Gille E, Aprotosoaie AC. Recent advances in tackling microbial multidrug resistance with essential oils: combinatorial and nano-based strategies. Crit Rev Microbiol. 2020;46(3):338–357.
   PubMed Web of Science ®Google Scholar
• Gentile V, Frangipani E, Bonchi C, Minandri F, Runci F, Visca P. Iron and Acinetobacter baumannii Biofilm formation. Pathogens. 2014;3(3):704–719.
   PubMedGoogle Scholar
• Upmanyu K, Singh R. Factors mediating Acinetobacter baumannii biofilm formation: opportunities for developing therapeutics. Curr Res Microb Sci. 2022;3:100131.
   PubMedGoogle Scholar
• Vestby LK, Grønseth T, Simm R, Nesse LL. Bacterial Biofilm and its Role in the Pathogenesis of Disease. Antibiotics. 2020;9(2):59.
   Google Scholar
• Dieltjens L, Appermans K, Lissens M, et al. Inhibiting bacterial cooperation is an evolutionarily robust anti-biofilm strategy. Nat Commun. 2020;11(1):1–11.
   PubMed Web of Science ®Google Scholar
• Shao L, Dong Y, Chen X, Xu X, Wang H. Modeling the elimination of mature biofilms formed by Staphylococcus aureus and Salmonella spp. In: Using Combined Ultrasound and Disinfectants. Ultrason Sonochem; 2020:69.
   Google Scholar
• Nadar S, Khan T, Patching SG, Omri A. Development of Antibiofilm Therapeutics Strategies to Overcome Antimicrobial Drug Resistance. Microorganisms. 2022;10:2.
   Web of Science ®Google Scholar
• Tursi SA, Puligedda RD, Szabo P, et al. Salmonella Typhimurium biofilm disruption by a human antibody that binds a pan-amyloid epitope on curli. Nat Commun. 2020;11(1):1007.
   PubMed Web of Science ®Google Scholar
• Steenackers H, Hermans K, Vanderleyden J, de Keersmaecker SCJ. Salmonella biofilms: an overview on occurrence, structure, regulation and eradication. Food Res Int. 2012;45(2):502–531.
   Web of Science ®Google Scholar
• Cadavid E, Echeverri F. The search for natural inhibitors of biofilm formation and the activity of the autoinductor C6-AHL in Klebsiella pneumoniae ATCC 13884. Biomolecules. 2019;9(2):49.
   PubMed Web of Science ®Google Scholar
• Santiago AJ, Burgos-Garay L. Bacteriophage treatment of carbapenemase-producing Klebsiella pneumoniae in a multispecies biofilm: a potential biocontrol strategy for healthcare facilities. AIMS Microbiol. 2020;6(1):43–63.
   PubMed Web of Science ®Google Scholar
• Chhibber S, Gondil VS, Sharma S, et al. Approach for Combating Klebsiella pneumoniae Biofilm Using Histidine Functionalized Silver Nanoparticles. Front Microbiol. 2017;8:1104.
   PubMed Web of Science ®Google Scholar
• Kaplan JB. Therapeutic potential of biofilm-dispersing enzymes. Int J Artif Organs. 2009;32(9):545–554.
   PubMed Web of Science ®Google Scholar
• Tosato MG, Schilardi P. Synergistic effect of carboxypterin and methylene blue applied to antimicrobial photodynamic therapy against mature biofilm of Klebsiella pneumoniae. Heliyon. 2020;6(3):e03522.
   PubMed Web of Science ®Google Scholar
• Bilici K, Atac N, Muti A, et al. Broad spectrum antibacterial photodynamic and photothermal therapy achieved with indocyanine green loaded SPIONs under near infrared irradiation. Biomater Sci. 2020;8(16):4616–4625.
   PubMed Web of Science ®Google Scholar
• Vuotto C, Longo F, Balice MP, Donelli G, Varaldo PE. Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens. 2014;3(3):743–758.
   PubMedGoogle Scholar
• Muhammad MH, Idris AL, Fan X, et al. Beyond Risk: bacterial Biofilms and Their Regulating Approaches. Front Microbiol. 2020;11(928):548.
   PubMedGoogle Scholar
• Suresh MK, Biswas R, Biswas L. An update on recent developments in the prevention and treatment of Staphylococcus aureus biofilms. Int J Med Microbiol. 2019;309(1):1–12.
   PubMed Web of Science ®Google Scholar
• Le KY, Park MD, Otto M. Immune Evasion Mechanisms of Staphylococcus epidermidis Biofilm Infection. Front Microbiol. 2018;9:359.
   PubMed Web of Science ®Google Scholar
• Chen W, Xie TT, Zeng H. Formation, Antibiotic Resistance, and Control Strategies of Staphylococcus Epidermidis Biofilm. IntechOpen; 2020.
   Google Scholar
• Bhattacharyya P, Agarwal B, Goswami M, Maiti D, Baruah S, Tribedi P. Zinc oxide nanoparticle inhibits the biofilm formation of Streptococcus pneumoniae. Antonie Van Leeuwenhoek. 2018;111(1):89–99.
   PubMed Web of Science ®Google Scholar
• Wang J, Song M, Pan J, et al. Quercetin impairs Streptococcus pneumoniae biofilm formation by inhibiting sortase A activity. J Cell Mol Med. 2018;22(12):6228–6237.
   PubMed Web of Science ®Google Scholar
• Yadav MK, Go YY, Chae SW, Song JJ. The Small Molecule DAM Inhibitor, Pyrimidinedione, Disrupts Streptococcus pneumoniae Biofilm Growth In Vitro. PLoS One. 2015;10(10):e0139238.
   PubMed Web of Science ®Google Scholar
• Lu L, Hu W, Tian Z, et al. Developing natural products as potential anti-biofilm agents. Chin Med. 2019;14(1):11.
   PubMed Web of Science ®Google Scholar
• Martínez OF, Cardoso MH, Ribeiro SM, Franco OL. Recent advances in anti-virulence therapeutic strategies with a focus on dismantling bacterial membrane microdomains, toxin neutralization, quorum-sensing interference and biofilm inhibition. Front Cell Infect Microbiol. 2019;9:74.
   PubMed Web of Science ®Google Scholar
• Bazaid AS, Aldarhami A, Patel M, et al. The Antimicrobial Effects of Saudi Sumra Honey against Drug Resistant Pathogens: phytochemical Analysis, Antibiofilm, Anti-Quorum Sensing, and Antioxidant Activities. Pharmaceuticals. 2022;15(10):1212.
   Web of Science ®Google Scholar
• Ghosh S, Lahiri D, Nag M, et al. Phytocompound Mediated Blockage of Quorum Sensing Cascade in ESKAPE Pathogens. Antibiotics. 2022;11(1):61.
   Google Scholar
• Singkham-In U, Higgins PG, Wannigama DL, Hongsing P, Chatsuwan T. Rescued chlorhexidine activity by resveratrol against carbapenem-resistant Acinetobacter baumannii via down-regulation of AdeB efflux pump. PLoS One. 2020;15(12):e0243082.
   PubMed Web of Science ®Google Scholar
• Bandeira junior G, Sutili FJ, Gressler LT, et al. Antibacterial potential of phytochemicals alone or in combination with antimicrobials against fish pathogenic bacteria. J Appl Microbiol. 2018;125(3):655–665.
   PubMed Web of Science ®Google Scholar
• Mishra R, Panda AK, de Mandal S, Shakeel M, Bisht SS, Khan J. Natural Anti-biofilm Agents: strategies to Control Biofilm-Forming Pathogens. Front Microbiol. 2020;11:566325.
   PubMed Web of Science ®Google Scholar
• Singh VK, Mishra A, Jha B. Anti-quorum sensing and anti-biofilm activity of Delftia tsuruhatensis extract by attenuating the quorum sensing-controlled virulence factor production in Pseudomonas aeruginosa. Front Cell Infect Microbiol. 2017;7:337.
   PubMed Web of Science ®Google Scholar
• Reen FJ, Gutiérrez-Barranquero JA, Parages ML, Gara F. Coumarin: a novel player in microbial quorum sensing and biofilm formation inhibition. Appl Microbiol Biotechnol. 2018;102(5):2063–2073.
   PubMed Web of Science ®Google Scholar
• Zhang J, Rui X, Wang L, Guan Y, Sun X, Dong M. Polyphenolic extract from Rosa rugosa tea inhibits bacterial quorum sensing and biofilm formation. Food Control. 2014;42:125–131.
   Web of Science ®Google Scholar
• Batohi N, Lone SA, Marimani M, Wani MY, Al-Bogami AS, Ahmad A. Citral and its derivatives inhibit quorum sensing and biofilm formation in Chromobacterium violaceum. Arch Microbiol. 2021;203(4):1451–1459.
   PubMed Web of Science ®Google Scholar
• Azeredo J, García P, Drulis-Kawa Z. Targeting biofilms using phages and their enzymes. Curr Opin Biotechnol. 2021;68:251–261.
   PubMed Web of Science ®Google Scholar
• Ingle AP, Wagh S, Biswas J, Mondal M, Feitosa CM, Rai M. Phyto-Fabrication of Different Nanoparticles and Evaluation of their Antibacterial and Anti-Biofilm Efficacy. Curr Nanosci. 2020;16(6):1002–1015.
   Web of Science ®Google Scholar
• Mogha K. Biofilm - A threat to dairy industry. Ind J Dairy Sci. 2014;67(6):459–466.
   Google Scholar
• Girennavar B, Cepeda ML, Soni KA, et al. Grapefruit juice and its furocoumarins inhibits autoinducer signaling and biofilm formation in bacteria. Int J Food Microbiol. 2008;125(2):204–208.
   PubMed Web of Science ®Google Scholar
• Bruni R, Barreca D, Protti M, et al. Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest. Molecules. 2019;24(11):2163.
   PubMed Web of Science ®Google Scholar
• D’Almeida RE, Molina RRDI, Viola CM, et al. Comparison of seven structurally related coumarins on the inhibition of Quorum sensing of Pseudomonas aeruginosa and Chromobacterium violaceum. Bioorg Chem. 2017;73:37–42.
   PubMed Web of Science ®Google Scholar
• Snoussi M, Noumi E, Hajlaoui H, et al. Phytochemical Profiling of Allium subhirsutum L. Aqueous Extract with Antioxidant, Antimicrobial, Antibiofilm, and Anti-Quorum Sensing Properties: in Vitro and In Silico Studies. Plants. 2022;11(4):495.
   Google Scholar
• Awadelkareem AM, Al-Shammari E, Elkhalifa AO, et al. Anti-Adhesion and Antibiofilm Activity of Eruca sativa Miller Extract Targeting Cell Adhesion Proteins of Food-Borne Bacteria as a Potential Mechanism: combined In Vitro-In Silico Approach. Plants. 2022;11(5):610.
   Google Scholar
• de Moura DF, Rocha TA, De melo Barros D, et al. Evaluation of the antioxidant, antibacterial, and antibiofilm activity of the sesquiterpene nerolidol. Arch Microbiol. 2021;203(7):4303–4311.
   PubMed Web of Science ®Google Scholar
• Emam M, Abdel-Haleem DR, Salem MM, et al. Phytochemical Profiling of Lavandula coronopifolia Poir. Aerial Parts Extract and Its Larvicidal, Antibacterial, and Antibiofilm Activity Against Pseudomonas aeruginosa. Molecules. 2021;26(6):1710.
   PubMed Web of Science ®Google Scholar
• Yang M, Meng F, Gu W, et al. Effects of Natural Products on Bacterial Communication and Network-Quorum Sensing. Biomed Res Int. 2020;2020:8638103.
   PubMed Web of Science ®Google Scholar
• Ackermann HW. Bacteriophage observations and evolution. Res Microbiol. 2003;154(4):245–251.
   PubMed Web of Science ®Google Scholar
• Breitbart M, Rohwer F. Here a virus, there a virus, everywhere the same virus? Trends Microbiol. 2005;13(6):278–284.
   PubMed Web of Science ®Google Scholar
• Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.
   PubMed Web of Science ®Google Scholar
• Vandamme EJ. Phage therapy and phage control: to be revisited urgently!! J Chem Technol Biotechnol. 2014;89(3):329–333.
   Web of Science ®Google Scholar
• Kortright KE, Chan BK, Koff JL, Turner PE. Phage Therapy: a Renewed Approach to Combat Antibiotic-Resistant Bacteria. Cell Host Microbe. 2019;25(2):219–232.
   PubMed Web of Science ®Google Scholar
• Fernández L, Gutiérrez D, García P, Rodríguez A. The perfect bacteriophage for therapeutic applications—A quick guide. Antibiotics. 2019;8(3):126.
   Google Scholar
• Hermoso JA, García JL, García P. Taking Aim on bacterial pathogens: from phage therapy to enzybiotics. Curr Opin Microbiol. 2007;10(5):461–472.
   PubMed Web of Science ®Google Scholar
• Ferriol-González C, Domingo-Calap P. Phages for Biofilm Removal. Antibiotics. 2020;9(5):268.
   Google Scholar
• Vázquez R, García P. Synergy Between Two Chimeric Lysins to Kill Streptococcus pneumoniae. Front Microbiol. 2019;10:1251.
   PubMed Web of Science ®Google Scholar
• Łubowska N, Piechowicz L. Staphylococcus aureus biofilm and the role of bacteriophages in its eradication. Postepy Hig Med Dosw. 2018;72:101–107.
   Web of Science ®Google Scholar
• Topka-Bielecka G, Dydecka A, Necel A, et al. Bacteriophage-derived depolymerases against bacterial biofilm. Antibiotics. 2021;10(2):1–21.
   Google Scholar
• Pires DP, Oliveira H, Melo LDR, Sillankorva S, Azeredo J. Bacteriophage-encoded depolymerases: their diversity and biotechnological applications. Appl Microbiol Biotechnol. 2016;100(5):2141–2151.
   PubMed Web of Science ®Google Scholar
• Loessner MJ. Bacteriophage endolysins—current state of research and applications. In: Current Opinion in Microbiology. Vol. 8. Elsevier; 2005:480–487.
   Google Scholar
• Young R, Wang IN, Roof WD. Phages will out: strategies of host cell lysis. Trends Microbiol. 2000;8(3):120–128.
   PubMed Web of Science ®Google Scholar
• Hasan M, Ahn J. Evolutionary Dynamics between Phages and Bacteria as a Possible Approach for Designing Effective Phage Therapies against Antibiotic-Resistant Bacteria. Antibiotics. 2022;11:7.
   Google Scholar
• Pei R, Lamas-Samanamud GR. Inhibition of Biofilm Formation by T7 Bacteriophages Producing Quorum-Quenching Enzymes. Appl Environ Microbiol. 2014;80(17):5340–5348.
   PubMed Web of Science ®Google Scholar
• Silpe JE, Bassler BL. Phage-encoded LuxR-type receptors responsive to host-produced bacterial quorum-sensing autoinducers. mBio. 2019;10(2):87.
   Web of Science ®Google Scholar
• Liu S, Lu H, Zhang S, Shi Y, Chen Q. Phages against Pathogenic Bacterial Biofilms and Biofilm-Based Infections: a Review. Pharmaceutics. 2022;14(2):427.
   PubMed Web of Science ®Google Scholar
• Luong T, Salabarria AC, Roach DR. Phage Therapy in the Resistance Era: where Do We Stand and Where Are We Going? Clin Ther. 2020;42(9):1659–1680.
   PubMed Web of Science ®Google Scholar
• Esteban PP, Alves DR, Enright MC, et al. Enhancement of the antimicrobial properties of bacteriophage-K via stabilization using oil-in-water nano-emulsions. Biotechnol Prog. 2014;30(4):932–944.
   PubMed Web of Science ®Google Scholar
• Esteban PP, Jenkins ATA, Arnot TC. Elucidation of the mechanisms of action of Bacteriophage K/nano-emulsion formulations against S. aureus via measurement of particle size and zeta potential. Colloids Surf B Biointerfaces. 2016;139:87–94.
   PubMed Web of Science ®Google Scholar
• Yu P, Wang Z, Marcos-Hernandez M, et al. Bottom-up biofilm eradication using bacteriophage-loaded magnetic nanocomposites: a computational and experimental study. Environ Sci Nano. 2019;6(12):3539–3550.
   Web of Science ®Google Scholar
• Liu ZH, Chiang MT, Lin HY. Lytic Bacteriophage as a Biomaterial to Prevent Biofilm Formation and Promote Neural Growth. Tissue Eng Regen Med. 2022;1–14.
   Web of Science ®Google Scholar
• Koshi E, Mohan A, Rajesh S, Philip K. Antimicrobial photodynamic therapy: an overview. J Indian Soc Periodontol. 2011;15(4):323.
   PubMedGoogle Scholar
• Polat E, Kang K. Natural Photosensitizers in Antimicrobial Photodynamic Therapy. Biomedicines. 2021;9(6):584.
   PubMed Web of Science ®Google Scholar
• Dascalu LM, Moldovan M, Prodan D, et al. Assessment and Characterization of Some New Photosensitizers for Antimicrobial Photodynamic Therapy (aPDT). Materials. 2020;13(13):3012.
   PubMed Web of Science ®Google Scholar
• Carrera ET, Dias HB, Corbi SCT, et al. The application of antimicrobial photodynamic therapy (aPDT) in dentistry: a critical review. Laser Phys. 2016;26(12):123001.
   PubMed Web of Science ®Google Scholar
• Hu X, Huang YY, Wang Y, Wang X, Hamblin MR. Antimicrobial photodynamic therapy to control clinically relevant biofilm infections. Front Microbiol. 2018;9:1299.
   PubMed Web of Science ®Google Scholar
• Cieplik F, Deng D, Crielaard W, et al. Antimicrobial photodynamic therapy–what we know and what we don’t. Crit Rev Microbiol. 2018;44(5):571–589.
   PubMed Web of Science ®Google Scholar
• Tavares LJ, de Avila ED, Klein MI, Panariello BHDD, Spolidório DMPP, Pavarina AC. Antimicrobial photodynamic therapy alone or in combination with antibiotic local administration against biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis. J Photochem Photobiol B. 2018;188:135–145.
   PubMed Web of Science ®Google Scholar
• Ghorbani J, Rahban D, Aghamiri S, Teymouri A, Bahador A. Photosensitizers in antibacterial photodynamic therapy: an overview. Laser Ther. 2018;27(4):293–302.
   PubMedGoogle Scholar
• Perez-Laguna V, Gilaberte Y, Millán-Lou MI, et al. A combination of photodynamic therapy and antimicrobial compounds to treat skin and mucosal infections: a systematic review. Photochem Photobiol Sci. 2019;18(5):1020–1029.
   PubMed Web of Science ®Google Scholar
• Chibebe junior J, Fuchs BB, Sabino CP, et al. Photodynamic and Antibiotic Therapy Impair the Pathogenesis of Enterococcus faecium in a Whole Animal Insect Model. PLoS One. 2013;8(2):e55926.
   PubMed Web of Science ®Google Scholar
• Dubey AK, Kumar Gupta V, Kujawska M, et al. Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases. J Nanostructure Chem. 2022;1–32.
   PubMed Web of Science ®Google Scholar
• Louwen R, Staals RHJ, Endtz HP, van Baarlen P, van der Oost J. The Role of CRISPR-Cas Systems in Virulence of Pathogenic Bacteria. Microbiol Mol Biol Rev. 2014;78(1):74–88.
   PubMed Web of Science ®Google Scholar
• Gong T, Zeng J, Tang B, Zhou X. CRISPR-Cas systems in oral microbiome: from immune defense to physiological regulation. Mol Oral Microbiol. 2020;35(2):41–48.
   PubMed Web of Science ®Google Scholar
• Ho C CRISPR gene-editing controversy shows old ideas about East and West still prevail. The Conversation; 2016. Available from: https://theconversation.com/crispr-gene-editing-controversy-shows-old-ideas-about-east-and-west-still-prevail-66918. Accessed December 15, 2022.
   Google Scholar
• Yadav N, Narang J, Chhillar AK, Rana JS. CRISPR: a new paradigm of theranostics. Nanomedicine. 2021;33:102350.
   PubMed Web of Science ®Google Scholar
• Hille F, Charpentier E. CRISPR-Cas: biology, mechanisms and relevance. Philos Trans R Soc B Biol Sci. 2016;371(1707):20150496.
   PubMed Web of Science ®Google Scholar
• Wiedenheft B, van Duijn E, Bultema J, et al. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc Natl Acad Sci U S A. 2011;108(25):10092–10097.
   PubMed Web of Science ®Google Scholar
• Paul B, Montoya G. CRISPR-Cas12a: functional overview and applications. Biomed J. 2020;43(1):8–17.
   PubMed Web of Science ®Google Scholar
• Zuberi A, Misba L, Khan AU. CRISPR interference (CRISPRi) inhibition of luxS gene expression in E. coli: an approach to inhibit biofilm. Front Cell Infect Microbiol. 2017;7:214.
   PubMed Web of Science ®Google Scholar
• Huang R, Li M, Gregory RL. Bacterial interactions in dental biofilm. Virulence. 2011;2(5):435–444.
   PubMed Web of Science ®Google Scholar
• Zuberi A, Ahmad N, Khan AU. CRISPRi induced suppression of fimbriae gene (fimH) of a Uropathogenic Escherichia coli: an approach to inhibit microbial biofilms. Front Immunol. 2017;8:1552.
   PubMed Web of Science ®Google Scholar
• Noirot-Gros MF, Forrester S, Malato G, Larsen PE, Noirot P. CRISPR interference to interrogate genes that control biofilm formation in Pseudomonas fluorescens. Sci Rep. 2019;9(1):1–14.
   PubMedGoogle Scholar
• Hegde S, Nilyanimit P, Kozlova E, et al. CRISPR/Cas9-mediated gene deletion of the ompA gene in symbiotic Cedecea neteri impairs biofilm formation and reduces gut colonization of Aedes aegypti mosquitoes. PLoS Negl Trop Dis. 2019;13(12):e0007883.
   PubMed Web of Science ®Google Scholar
• Moon S, Kim DY, Ko JH, Kim YS. Recent advances in the CRISPR genome editing tool set. Exp Mol Med. 2019;51(11):1–11.
   Google Scholar
• Makabenta JM, Nabawy A, Li CH, Schmidt-Malan S, Patel R, Rotello VM. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nat Rev Microbiol. 2021;19(1):23–36.
   PubMed Web of Science ®Google Scholar
• Abdalla SSI, Katas H, Azmi F, Busra MFM. Antibacterial and Anti-Biofilm Biosynthesised Silver and Gold Nanoparticles for Medical Applications: mechanism of Action, Toxicity and Current Status. Curr Drug Deliv. 2020;17(2):88–100.
   PubMed Web of Science ®Google Scholar
• Geissel FJ, Platania V, Gogos A, et al. Antibiofilm activity of nanosilver coatings against Staphylococcus aureus. J Colloid Interface Sci. 2022;608:3141–3150.
   PubMed Web of Science ®Google Scholar
• Mohammad MA, Faris Taufeq FY. Roles of chitosan in synthesis, antibacterial and anti-biofilm properties of bionano silver and gold. RSC Adv. 2022;12(30):19297–19312.
   PubMed Web of Science ®Google Scholar
• Luzala MM, Muanga CK, Kyana J, et al. A Critical Review of the Antimicrobial and Antibiofilm Activities of Green-Synthesized Plant-Based Metallic Nanoparticles. Nanomaterials. 2022;12(11):1841.
   Web of Science ®Google Scholar
• Al-Azawi M, Hadi SM, Mohammed C. Synthesis of silica nanoparticles via green approach by using hot aqueous extract of Thuja orientalis leaf and their effect on biofilm formation. Iraqi J Agric Sci. 2019;50:245–255.
   Google Scholar
• Shehabeldine AM, Amin BH, Hagras FA, et al. Potential Antimicrobial and Antibiofilm Properties of Copper Oxide Nanoparticles: time-Kill Kinetic Essay and Ultrastructure of Pathogenic Bacterial Cells. Appl Biochem Biotechnol. 2022;1–19.
   Web of Science ®Google Scholar
• Maksoud MIAA, El-Sayyad GS, Ashour AH, et al. Antibacterial, antibiofilm, and photocatalytic activities of metals-substituted spinel cobalt ferrite nanoparticles. Microb Pathog. 2019;127:144–158.
   PubMed Web of Science ®Google Scholar
• Takamiya AS, Monteiro DR, Gorup LF, et al. Biocompatible silver nanoparticles incorporated in acrylic resin for dental application inhibit Candida albicans biofilm. Mater Sci Eng C Mater Biol Appl. 2021;118.
   Web of Science ®Google Scholar
• Dias HB, Bernardi MIB, Bauab TM, Hernandes AC. Titanium dioxide and modified titanium dioxide by silver nanoparticles as an anti biofilm filler content for composite resins. Dent Mater. 2019;35(2):e36–e46.
   PubMed Web of Science ®Google Scholar
• Al-Wrafy FA, Al-Gheethi AA, Ponnusamy SK, Noman EA, Fattah SA. Nanoparticles approach to eradicate bacterial biofilm-related infections: a critical review. Chemosphere. 2022;288:132603.
   PubMed Web of Science ®Google Scholar
• Qais FA, Khan MS, Ahmad I. Nanoparticles as Quorum Sensing Inhibitor: prospects and Limitations. In: Biotechnological Applications of Quorum Sensing Inhibitors. Springer; 2018:227–244.
   Google Scholar
• Mao BH, Chen ZY, Wang YJ, Yan SJ. Silver nanoparticles have lethal and sublethal adverse effects on development and longevity by inducing ROS-mediated stress responses. Sci Rep. 2018;8(1):1–16.
   PubMedGoogle Scholar
• Darabpour E, Kashef N, Amini SM, Kharrazi S, Djavid GE. Fast and effective photodynamic inactivation of 4-day-old biofilm of methicillin-resistant Staphylococcus aureus using methylene blue-conjugated gold nanoparticles. J Drug Deliv Sci Technol. 2017;37:134–140.
   Web of Science ®Google Scholar
• Wan T, Pan Q, Ping Y. Microneedle-assisted genome editing: a transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders. Sci Adv. 2021;7(11):eabe2888.
   PubMed Web of Science ®Google Scholar
• Barhoum A, García-Betancourt ML, Jeevanandam J, et al. Review on Natural, Incidental, Bioinspired, and Engineered Nanomaterials: history, Definitions, Classifications, Synthesis, Properties, Market, Toxicities, Risks, and Regulations. Nanomaterials. 2022;12(2):177.
   Web of Science ®Google Scholar
• Kiani MH, Imran M, Raza A, Shahnaz G. Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance. DARU J Pharm Sci. 2020;28(1):319–332.
   Web of Science ®Google Scholar
• Franco D, Calabrese G, Guglielmino SPP, Conoci S. Metal-Based Nanoparticles: antibacterial Mechanisms and Biomedical Application. Microorganisms. 2022;10(9):1778.
   PubMed Web of Science ®Google Scholar
• Jang J, Lee JM. Development of Antibiofilm Nanocomposites: ag/Cu Bimetallic Nanoparticles Synthesized on the Surface of Graphene Oxide Nanosheets. ACS Appl Mater Interfaces. 2020;12(32):35826–35834.
   PubMed Web of Science ®Google Scholar
• Khalid HF, Tehseen B, Sarwar Y, et al. Biosurfactant coated silver and iron oxide nanoparticles with enhanced anti-biofilm and anti-adhesive properties. J Hazard Mater. 2019;364:441–448.
   PubMed Web of Science ®Google Scholar
• El-Batal AI, Al-Hazmi NE, Farrag AA, et al. Antimicrobial synergism and antibiofilm activity of amoxicillin loaded citric acid-magnesium ferrite nanocomposite: effect of UV-illumination, and membrane leakage reaction mechanism. Microb Pathog. 2022;164:105440.
   PubMed Web of Science ®Google Scholar
• Padmavathi AR, Sriyutha Murthy P, Das A, Nishad PA, Pandian R, Rao TS. Copper oxide nanoparticles as an effective anti-biofilm agent against a copper tolerant marine bacterium, Staphylococcus lentus. Biofouling. 2019;35(9):1007–1025.
   PubMed Web of Science ®Google Scholar
• Rónavári A, Igaz N, Adamecz DI, et al. Green Silver and Gold Nanoparticles: biological Synthesis Approaches and Potentials for Biomedical Applications. Molecules. 2021;26(4):844.
   PubMed Web of Science ®Google Scholar
• Vallet-Regí M, González B, Izquierdo-Barba I. Nanomaterials as Promising Alternative in the Infection Treatment. Int J Mol Sci. 2019;20(15):3806.
   PubMed Web of Science ®Google Scholar
• Nisar P, Ali N, Rahman L, Ali M, Shinwari ZK. Antimicrobial activities of biologically synthesized metal nanoparticles: an insight into the mechanism of action. J Biol Inorg Chem. 2019;24(7):929–941.
   PubMed Web of Science ®Google Scholar
• Zhang D, Ma XL, Gu Y, Huang H, Zhang GW. Green Synthesis of Metallic Nanoparticles and Their Potential Applications to Treat Cancer. Front Chem. 2020;8:3256.
   Web of Science ®Google Scholar
• Xu M, Yim W, Zhou J, et al. The Application of Organic Nanomaterials for Bioimaging, Drug Delivery, and Therapy: spanning Various Domains. IEEE Nanotechnol Mag. 2021;15(4):8–28.
   Web of Science ®Google Scholar
• Ng KK, Zheng G. Molecular Interactions in Organic Nanoparticles for Phototheranostic Applications. Chem Rev. 2015;115(19):11012–11042.
   PubMed Web of Science ®Google Scholar
• Gonzalez Gomez A, Hosseinidoust Z. Liposomes for Antibiotic Encapsulation and Delivery. ACS Infect Dis. 2020;6(5):896–908.
   PubMed Web of Science ®Google Scholar
• Chauhan SB, Gupta V. Recent Advances in Liposome. Res J Pharm Technol. 2020;13(4):2051–2056.
   Google Scholar
• Alavi SE, Koohi Moftakhari Esfahani, M, Raza, A, Adelnia, H, Ebrahimi Shahmabad, H. PEG-grafted liposomes for enhanced antibacterial and antibiotic activities: an in vivo study. NanoImpact. 2022;25:100384.
   PubMed Web of Science ®Google Scholar
• Chen XF, Zhao X, Yang Z. Aptamer-Based Antibacterial and Antiviral Therapy against Infectious Diseases. J Med Chem. 2021;64(24):17601–17626.
   PubMed Web of Science ®Google Scholar
• Allemailem KS, Almatroudi A, Alsahli MA, et al. Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents. 3 Biotech. 2020;10:12.
   PubMedGoogle Scholar
• Das A, Konyak PM, Das A, Dey SK, Saha C. Physicochemical characterization of dual action liposomal formulations: anticancer and antimicrobial. Heliyon. 2019;5:8.
   Web of Science ®Google Scholar
• Ghandhariyoun N, Jaafari MR, Nikoofal-Sahlabadi S, Taghdisi SM, Moosavian SA. Reducing Doxorubicin resistance in breast cancer by liposomal FOXM1 aptamer: in vitro and in vivo. Life Sci. 2020;262.
   Web of Science ®Google Scholar
• Zhou C, You T, Jang H, et al. Aptamer-Conjugated Polydiacetylene Colorimetric Paper Chip for the Detection of Bacillus thuringiensis Spores. Sensors. 2020;20:11.
   Web of Science ®Google Scholar
• Hallan SS, Marchetti P, Bortolotti D, et al. Design of Nanosystems for the Delivery of Quorum Sensing Inhibitors: a Preliminary Study. Molecules. 2020;25(23):5655.
   PubMed Web of Science ®Google Scholar
• Ibaraki H, Kanazawa T, Chien WYY, et al. The effects of surface properties of liposomes on their activity against Pseudomonas aeruginosa PAO-1 biofilm. J Drug Deliv Sci Technol. 2020;57:101754.
   Web of Science ®Google Scholar
• Ayllon M, Abatchev G, Bogard A, Whiting R, Hobdey SE, Fologea D. Liposomes prevent in vitro hemolysis induced by streptolysin o and lysenin. Membranes. 2021;11(5):364.
   PubMed Web of Science ®Google Scholar
• Kumar S, Paliya BS, Singh BN. Superior inhibition of virulence and biofilm formation of Pseudomonas aeruginosa PAO1 by phyto-synthesized silver nanoparticles through anti-quorum sensing activity. Microb Pathog. 2022;170:105678.
   PubMed Web of Science ®Google Scholar
• da Silveira SA, Perez A. Liposomes as novel anti-infectives targeting bacterial virulence factors? Expert Rev Anti Infect Ther. 2015;13(5):531–533.
   PubMed Web of Science ®Google Scholar
• Agarwal H, Nakara A, Shanmugam VK. Anti-inflammatory mechanism of various metal and metal oxide nanoparticles synthesized using plant extracts: a review. Biomed Pharmacother. 2019;109:2561–2572.
   PubMed Web of Science ®Google Scholar
• Mauricio MD, Guerra-Ojeda S, Marchio P, et al. Nanoparticles in medicine: a focus on vascular oxidative stress. Oxid Med Cell Longev. 2018;2018:879.
   Web of Science ®Google Scholar